David shares his groundbreaking journey in using ketamine for depression, highlighting its distinct mechanism that targets glutamate rather than traditional neurotransmitters. Unlike conventional antidepressants, the therapeutic environment and the patient's mindset significantly influence the treatment's effectiveness, marking a shift in how mental health therapies are approached. This innovative perspective opens new avenues for understanding and treating mental illness.
